BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shaik K, Deb PK, Mailavaram RP, Chandrasekaran B, Kachler S, Klotz K, Jaber AMY. 7‐Amino‐2‐aryl/hetero‐aryl‐5‐oxo‐5,8‐dihydro[1,2,4]triazolo[1,5‐ a ]pyridine‐6‐carbonitriles: Synthesis and adenosine receptor binding studies. Chem Biol Drug Des 2019. [DOI: 10.1111/cbdd.13528] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Choudhury H, Chellappan DK, Sengupta P, Pandey M, Gorain B. Adenosine Receptors in Modulation of Central Nervous System Disorders. Curr Pharm Des 2019;25:2808-27. [PMID: 31309883 DOI: 10.2174/1381612825666190712181955] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
2 Al-attraqchi OH, Attimarad M, Venugopala KN, Nair A, Al-attraqchi NH. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives. CPD 2019;25:2716-40. [DOI: 10.2174/1381612825666190716113444] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
3 Borah P, Deka S, Mailavaram RP, Deb PK. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future. Curr Pharm Des 2019;25:2792-807. [PMID: 31333097 DOI: 10.2174/1381612825666190716111245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
4 Jamwal S, Mittal A, Kumar P, Alhayani DM, Al-Aboudi A. Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors. Curr Pharm Des 2019;25:2892-905. [PMID: 31333104 DOI: 10.2174/1381612825666190716112319] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
5 Marwein S, Mishra B, De UC, Acharya PC. Recent Progress of Adenosine Receptor Modulators in the Development of Anticancer Chemotherapeutic Agents. CPD 2019;25:2842-58. [DOI: 10.2174/1381612825666190716141851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Gorain B, Choudhury H, Yee GS, Bhattamisra SK. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers. CPD 2019;25:2828-41. [DOI: 10.2174/1381612825666190716102037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Pal Y, Bandyopadhyay N, Pal RS, Ahmed S, Bandopadhyay S. Perspective and Potential of A2A and A3 Adenosine Receptors as Therapeutic Targets for the Treatment of Rheumatoid Arthritis. CPD 2019;25:2859-74. [DOI: 10.2174/1381612825666190710111658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Mailavaram RP, Al-attraqchi OH, Kar S, Ghosh S. Current Status in the Design and Development of Agonists and Antagonists of Adenosine A3 Receptor as Potential Therapeutic Agents. CPD 2019;25:2772-87. [DOI: 10.2174/1381612825666190716114056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Agrawal N, Chandrasekaran B, Al-aboudi A. Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor. CPD 2019;25:774-82. [DOI: 10.2174/1381612825666190306162006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
10 Matthee C, Terre'Blanche G, Legoabe LJ, Janse van Rensburg HD. Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development. Mol Divers 2021. [PMID: 34176057 DOI: 10.1007/s11030-021-10257-9] [Reference Citation Analysis]
11 Deb PK, Deka S, Borah P, Abed SN, Klotz KN. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives. Curr Pharm Des 2019;25:2697-715. [PMID: 31333094 DOI: 10.2174/1381612825666190716100509] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
12 Shakya AK, Naik RR, Almasri IM, Kaur A. Role and Function of Adenosine and its Receptors in Inflammation, Neuroinflammation, IBS, Autoimmune Inflammatory Disorders, Rheumatoid Arthritis and Psoriasis. Curr Pharm Des 2019;25:2875-91. [PMID: 31333103 DOI: 10.2174/1381612825666190716145206] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chandrasekaran B, Samarneh S, Jaber AMY, Kassab G, Agrawal N. Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives. Curr Pharm Des 2019;25:2741-71. [PMID: 31333084 DOI: 10.2174/1381612825666190717105834] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]